Publications by authors named "Susan C Low"

Claim this Profile
X
Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.
Tatsuo Kawai, Winfred W Williams, Nahel Elias, Jay A Fishman, Kerry Crisalli, Susan C Low

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and testing of a humanized porcine donor for xenotransplantation.
Ranjith P Anand, Jacob V Layer, David Heja, Takayuki Hirose, Grace Lassiter, Susan C Low

Nature· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Daniel D Von Hoff, Monica M Mita, Ramesh K Ramanathan, Glen J Weiss, Alain C Mita, Lowell L Hart, Susan C Low

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs.
Jennifer A Dumont, Tongyao Liu, Susan C Low, Xin Zhang, George Kamphaus

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats.
Adam R Mezo, Kevin A McDonnell, Susan C Low, Jeff Song, Tom J Reidy

Bioconjug Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylation enhances the therapeutic potential of peptide antagonists of the neonatal Fc receptor, FcRn.
Adam R Mezo, Susan C Low, Todd Hoehn, Holly Palmieri

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged activity of factor IX as a monomeric Fc fusion protein.
Robert T Peters, Susan C Low, George D Kamphaus, Jennifer A Dumont, John V Amari

Blood· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of dimeric peptide antagonists of the human immunoglobulin G-human neonatal Fc receptor (IgG-FcRn) interaction.
Kevin A McDonnell, Susan C Low, Todd Hoehn, Ryan Donnelly, Holly Palmieri

J Med Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of the FcRn:IgG protein-protein interaction.
Susan C Low, Adam R Mezo

AAPS J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.
Adam R Mezo, Kevin A McDonnell, Cristina A Tan Hehir, Susan C Low, Vito J Palombella

Proc Natl Acad Sci U S A· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics.
Jennifer A Dumont, Susan C Low, Robert T Peters, Alan J Bitonti

BioDrugs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway.
Alan J Bitonti, Jennifer A Dumont, Susan C Low, Robert T Peters, Keith E Kropp

Proc Natl Acad Sci U S A· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis